You are now in the main content area

About

Prof. Douplik’s Ryerson Photonics Group comprises 2 labs:

The Ryerson Campus Photonics Lab (Dry Lab) is located in Kerr Hall East (2nd floor), and the St. Michael's Hospital Photonics Lab (Wet & Clinical Lab) is located at the Institute of Biomedical Engineering, Science and Technologies (iBEST) (external link, opens in new window) , Keenan Research Centre of the Li Ka Shing Knowledge Institute at St. Michael Hospital (external link, opens in new window) . These two labs are 7-8 min walk away from each other.

The Ryerson Campus Photonics Lab (Dry Lab), where Prof. Douplik and his students develop optoelectronics and software, occupies more than 150 m2 and equipped with optics, mechanics, electronics, lasers, light sources, bio and industrial microscopes, holographic stand, cameras, signal generators, fiber optics and powerful computers for data processing. The St. Michael's Hospital Photonics Lab (Wet & Clinical Lab) at iBEST, is equipped with multiwavelength refractometer, chemical lab desks, has access to high end spectrometers, clean production, cell culture and animal facilities.

Prof. Douplik’s group works on projects, which are related to Biomedical Physics employing Optics as the main tool. It includes medical lasers, advanced spectroscopy and imaging, both therapeutic or surgical, and diagnostic applications.

The main principle of the Group priority strategy is based on developing technologies, which can solve a concrete highly demanded Health Care problem and be eventually commercialized. The project target is usually found within framework of collaboration with clinical partners. Each student works on an individual project developing an original medical technology. When the project progresses, the authorship and contribution of each student involved is recognized. A patent, IP disclosure and/or peer-reviewed publication(s) are supposed to be submitted as a result of every single graduate project.

Students are encouraged to proceed with project’s technology commercialization to be personally supported by Prof. Douplik, Ryerson Lab2Market initiative, Ryerson Business Development and Ryerson Zones’ infrastructure.